Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05169073

Virtual Reality Training for Laparoscopic Cholecystectomy

The Impact of 3D Virtual Reality MRCP Rendering on Surgical Performance During Laparoscopic Cholecystectomy: A Pilot Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
22 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Cholecystectomy is one the most frequent laparoscopic procedures worldwide. It is a safe and effective operation but intraoperative bile duct injury remains a relevant complication with serious consequences for the patient. Most of the complications occur due to a lack of knowledge of the anatomy or misidentification of the cystic duct. Thus, the study of the anatomy is a cornerstone of a successful procedure and the preoperative magnetic resonance cholangiopancreatography (MRCP) is a way to preoperatively determine relevant structures to avoid intraoperative incidents. This trial has been designed to assess the effect of preoperative virtual reality training based on MRCP on intraoperative performance and outcome.

Conditions

Interventions

TypeNameDescription
PROCEDUREVirtual Reality trainingIn the Virtual Reality (VR) study arm, a VR software (Specto VRTM, version 4.0, Diffuse Ltd, Heimberg, Switzerland) will be used to display volumetric MRCP data using a tethered head-mounted display (HMD) prior to the operation. Specto uses volume rendering at 180 frames/sec to visualize the medical data in an immersive fashion in the VR environment and allows for viewing of the 3D reconstructed 3D imaging with 360° free movement. Each participant will perform a procedure with VR training and one with conventional preparation (MRCP).
PROCEDUREConventional trainingIn the conventional study arm, the participants will view the preoperative MRCP.

Timeline

Start date
2021-11-01
Primary completion
2025-12-31
Completion
2026-06-30
First posted
2021-12-23
Last updated
2025-04-15

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05169073. Inclusion in this directory is not an endorsement.